University of North Carolina Lineberger Comprehensive Cancer Center scientist Antonio “Tony” Amelio, PhD, is not necessarily looking for the “smoking gun” of cancer biology, or one single cause of cancer. Instead, he’s looking into how a family of newly described proteins involved in the cellular stress response can cause a complex ripple effect of changes … Continued
At the 60th American Society of Hematology Annual Meeting in San Diego on Monday, UNC Lineberger’s Natalie Grover, MD, presented preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.
UNC Lineberger’s Bhishamjit S. Chera, MD, will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology on Tuesday from a study that evaluated a blood test for HPV-linked oropharyngeal squamous cell carcinoma, which is a cancer of the back of the throat. The findings demonstrated the test could be an effective and less costly alternative for monitoring for cancer recurrence after radiation treatment.
UNC Lineberger’s Daniel Reuland, MD, MPH, and colleagues published in JAMA Internal Medicine a review of data from 73 randomized clinical trials that tested different ways of increasing screening for colorectal cancer. Their analysis identified three approaches as being the most effective.
In an article in the journal Nature Reviews Gastroenterology & Hepatology, UNC Lineberger’s Stephen Hursting, PhD, MPH, and his colleagues reviewed findings from research looking at the biological links between obesity and cancers of the colon, rectum, pancreas, liver, esophagus, gallbladder and stomach, as well as published studies on how diet, exercise, weight loss surgery, and other weight-related interventions may help reverse this connection.
A study led by UNC Lineberger’s Stephanie Wheeler, PhD, found that black women were more likely than white women to report not taking endocrine therapy for breast cancer as prescribed, which could help explain why hormone-receptor positive breast cancer mortality is higher among black women.